search

1-20 of 46

Save search

Sort by

Sort Order Select

2 3

Journal Article

MBCL-01. VINCRISTINE NEUROTOXICITY UNMASKING CHARCOT-MARIE-TOOTH DISEASE

PDF

Trisha Kissoon and Sridharan Gururangan

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i118, https://doi.org/10.1093/neuonc/noy059.402

Published: 22 June 2018

Journal Article

MBCL-02. CURRENT ISSUES IN THE MANAGEMENT OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA IN YOUNG CHILDREN

PDF

Mohamed AbdelBaki and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i118, https://doi.org/10.1093/neuonc/noy059.403

Published: 22 June 2018

Journal Article

MBCL-08. MOLECULAR CHARACTERIZATION OF NODULAR DESMOPLASTIC MEDULLOBLASTOMAS IN YOUNG CHILDREN TREATED ON ACNS1221. A REPORT FROM THE CHILDREN ONCOLOGY GROUP

PDF

Lucie Lafay-Cousin and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i118–i119, https://doi.org/10.1093/neuonc/noy059.406

Published: 22 June 2018

Journal Article

MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE

PDF

Michelle Kameda-Smith and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i119, https://doi.org/10.1093/neuonc/noy059.407

Published: 22 June 2018

Journal Article

MBCL-10. TREATMENT OUTCOMES AND COMPLICATION RATES OF SINGLE VERSUS TANDEM AUTOLOGOUS TRANSPLANT FOR REGIMENS FOR MEDULLOBLASTOMA

PDF

Ashley S Plant and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i119, https://doi.org/10.1093/neuonc/noy059.408

Published: 22 June 2018

Journal Article

MBCL-11. CONCURRENT IDH1 AND SMARCB1 MUTATIONS IN A PEDIATRIC MEDULLOBLASTOMA: A CASE REPORT

PDF

Moatasem El-Ayadi and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i119, https://doi.org/10.1093/neuonc/noy059.409

Published: 22 June 2018

Journal Article

MBCL-14. MOLECULAR GENETIS BIOMARKERS FOR PROGNISIS DEFINING IN MEDULLOBLASTOMA PATIENTS

PDF

Alexander Druy and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i120, https://doi.org/10.1093/neuonc/noy059.412

Published: 22 June 2018

Journal Article

MBCL-18. CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA

PDF

Nidhi Shah and Andrew Walter

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i120, https://doi.org/10.1093/neuonc/noy059.415

Published: 22 June 2018

Journal Article

MBCL-32. SAFETY AND EFFICACY OF CONCURRENT CARBOPLATIN DURING CRANIOSPINAL IRRADIATION FOR HIGH-RISK/ MEDULLOBLASTOMA IN A RESOURCE-LIMITED SETTING

PDF

Tejpal Gupta and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i123–i124, https://doi.org/10.1093/neuonc/noy059.428

Published: 22 June 2018

Journal Article

MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

PDF

Mohammad H Abu Arja and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i124, https://doi.org/10.1093/neuonc/noy059.429

Published: 22 June 2018

Journal Article

MBCL-37. SECONDARY PRIMARY TUMOR AND SURVIVAL OUTCOME IN MEDULLOBLASTOMA: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) ANALYSIS

PDF

Chonnipa Nantavithya and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i125, https://doi.org/10.1093/neuonc/noy059.433

Published: 22 June 2018

Journal Article

MBCL-38. MEDULLOBLASTOMAS ASSOCIATED WITH APC GERMLINE MUTATION: A MULTICENTRIC FRENCH AND BELGIAN REVIEW

PDF

Aurore Surun and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i125, https://doi.org/10.1093/neuonc/noy059.434

Published: 22 June 2018

Journal Article

MBCL-39. MEDULLOBLASTOMA IN PATIENTS WITH GORLIN SYNDROME: RESULTS FROM THE HIT STUDY GROUP

PDF

Barbara Meissner and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i125, https://doi.org/10.1093/neuonc/noy059.435

Published: 22 June 2018

Journal Article

MBCL-41. TREATMENT FAILURE PATTERNS ACROSS MEDULLOBLASTOMA SUBGROUPS WITHIN A PROSPECTIVE PHASE II CLINICAL TRIAL OF RISK-ADAPTED, VOLUME-REDUCED RADIATION THERAPY AND DOSE-INTENSE CHEMOTHERAPY WITH STEM CELL SUPPORT

PDF

Christopher Tinkle and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i126, https://doi.org/10.1093/neuonc/noy059.437

Published: 22 June 2018

Journal Article

MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

PDF

Giles W Robinson and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i126–i127, https://doi.org/10.1093/neuonc/noy059.440

Published: 22 June 2018

Journal Article

MBCL-46. COMPOUND HETEROZYGOUS MUTATION OF THE PMS2 GENE IN AN INFANT WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY AND MEDULLOBLASTOMA

PDF

Claudia Lukas and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i127, https://doi.org/10.1093/neuonc/noy059.442

Published: 22 June 2018

Journal Article

MBCL-48. HEARING CHEMOPROTECTION WITH SODIUM THIOSULFATE (STS) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH STANDARD RISK MEDULLOBLASTOMA

PDF

Edward Neuwelt and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i127–i128, https://doi.org/10.1093/neuonc/noy059.444

Published: 22 June 2018

Journal Article

MBCL-49. PROGNOSTIC SIGNIFICANCE OF MOLECULAR SUBGROUPS OF MEDULLOBLASTOMA IN CHILDREN RECEIVING IRRADIATION-SPARING REGIMENS

PDF

Kee Kiat Yeo and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i128, https://doi.org/10.1093/neuonc/noy059.445

Published: 22 June 2018

Journal Article

MBCL-06. SUCCESSFUL SALVAGE OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA PATIENTS TREATED ON ACNS1221

PDF

Richard T Graham and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i118, https://doi.org/10.1093/neuonc/noy059.404

Published: 22 June 2018

Journal Article

MBCL-12. METASTATIC DISEASE IN THE SUPRASELLAR AREA AT DIAGNOSIS IN MEDULLOBLASTOMA

PDF

Helen Toledano and others

Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i119, https://doi.org/10.1093/neuonc/noy059.410

Published: 22 June 2018

2 3

Modify your search

Availability

NARROW

Format

Type

Section

Publication date

MBCL-01. VINCRISTINE NEUROTOXICITY UNMASKING CHARCOT-MARIE-TOOTH DISEASE

MBCL-02. CURRENT ISSUES IN THE MANAGEMENT OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA IN YOUNG CHILDREN

MBCL-08. MOLECULAR CHARACTERIZATION OF NODULAR DESMOPLASTIC MEDULLOBLASTOMAS IN YOUNG CHILDREN TREATED ON ACNS1221. A REPORT FROM THE CHILDREN ONCOLOGY GROUP

MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE

MBCL-10. TREATMENT OUTCOMES AND COMPLICATION RATES OF SINGLE VERSUS TANDEM AUTOLOGOUS TRANSPLANT FOR REGIMENS FOR MEDULLOBLASTOMA

MBCL-11. CONCURRENT IDH1 AND SMARCB1 MUTATIONS IN A PEDIATRIC MEDULLOBLASTOMA: A CASE REPORT

MBCL-14. MOLECULAR GENETIS BIOMARKERS FOR PROGNISIS DEFINING IN MEDULLOBLASTOMA PATIENTS

MBCL-18. CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA

MBCL-32. SAFETY AND EFFICACY OF CONCURRENT CARBOPLATIN DURING CRANIOSPINAL IRRADIATION FOR HIGH-RISK/ MEDULLOBLASTOMA IN A RESOURCE-LIMITED SETTING

MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

MBCL-37. SECONDARY PRIMARY TUMOR AND SURVIVAL OUTCOME IN MEDULLOBLASTOMA: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) ANALYSIS

MBCL-38. MEDULLOBLASTOMAS ASSOCIATED WITH APC GERMLINE MUTATION: A MULTICENTRIC FRENCH AND BELGIAN REVIEW

MBCL-39. MEDULLOBLASTOMA IN PATIENTS WITH GORLIN SYNDROME: RESULTS FROM THE HIT STUDY GROUP

MBCL-41. TREATMENT FAILURE PATTERNS ACROSS MEDULLOBLASTOMA SUBGROUPS WITHIN A PROSPECTIVE PHASE II CLINICAL TRIAL OF RISK-ADAPTED, VOLUME-REDUCED RADIATION THERAPY AND DOSE-INTENSE CHEMOTHERAPY WITH STEM CELL SUPPORT

MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

MBCL-46. COMPOUND HETEROZYGOUS MUTATION OF THE PMS2 GENE IN AN INFANT WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY AND MEDULLOBLASTOMA

MBCL-48. HEARING CHEMOPROTECTION WITH SODIUM THIOSULFATE (STS) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH STANDARD RISK MEDULLOBLASTOMA

MBCL-49. PROGNOSTIC SIGNIFICANCE OF MOLECULAR SUBGROUPS OF MEDULLOBLASTOMA IN CHILDREN RECEIVING IRRADIATION-SPARING REGIMENS

MBCL-06. SUCCESSFUL SALVAGE OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA PATIENTS TREATED ON ACNS1221

MBCL-12. METASTATIC DISEASE IN THE SUPRASELLAR AREA AT DIAGNOSIS IN MEDULLOBLASTOMA

Email alerts

Modify your search

Publication date

MBCL-01. VINCRISTINE NEUROTOXICITY UNMASKING CHARCOT-MARIE-TOOTH DISEASE Free

MBCL-02. CURRENT ISSUES IN THE MANAGEMENT OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA IN YOUNG CHILDREN Free

MBCL-08. MOLECULAR CHARACTERIZATION OF NODULAR DESMOPLASTIC MEDULLOBLASTOMAS IN YOUNG CHILDREN TREATED ON ACNS1221. A REPORT FROM THE CHILDREN ONCOLOGY GROUP Free

MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE Free

MBCL-10. TREATMENT OUTCOMES AND COMPLICATION RATES OF SINGLE VERSUS TANDEM AUTOLOGOUS TRANSPLANT FOR REGIMENS FOR MEDULLOBLASTOMA Free

MBCL-11. CONCURRENT IDH1 AND SMARCB1 MUTATIONS IN A PEDIATRIC MEDULLOBLASTOMA: A CASE REPORT Free

MBCL-14. MOLECULAR GENETIS BIOMARKERS FOR PROGNISIS DEFINING IN MEDULLOBLASTOMA PATIENTS Free

MBCL-18. CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA Free

MBCL-32. SAFETY AND EFFICACY OF CONCURRENT CARBOPLATIN DURING CRANIOSPINAL IRRADIATION FOR HIGH-RISK/ MEDULLOBLASTOMA IN A RESOURCE-LIMITED SETTING Free

MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS Free

MBCL-37. SECONDARY PRIMARY TUMOR AND SURVIVAL OUTCOME IN MEDULLOBLASTOMA: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) ANALYSIS Free

MBCL-38. MEDULLOBLASTOMAS ASSOCIATED WITH APC GERMLINE MUTATION: A MULTICENTRIC FRENCH AND BELGIAN REVIEW Free

MBCL-39. MEDULLOBLASTOMA IN PATIENTS WITH GORLIN SYNDROME: RESULTS FROM THE HIT STUDY GROUP Free

MBCL-41. TREATMENT FAILURE PATTERNS ACROSS MEDULLOBLASTOMA SUBGROUPS WITHIN A PROSPECTIVE PHASE II CLINICAL TRIAL OF RISK-ADAPTED, VOLUME-REDUCED RADIATION THERAPY AND DOSE-INTENSE CHEMOTHERAPY WITH STEM CELL SUPPORT Free

MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07) Free

MBCL-46. COMPOUND HETEROZYGOUS MUTATION OF THE PMS2 GENE IN AN INFANT WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY AND MEDULLOBLASTOMA Free

MBCL-48. HEARING CHEMOPROTECTION WITH SODIUM THIOSULFATE (STS) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH STANDARD RISK MEDULLOBLASTOMA Free

MBCL-49. PROGNOSTIC SIGNIFICANCE OF MOLECULAR SUBGROUPS OF MEDULLOBLASTOMA IN CHILDREN RECEIVING IRRADIATION-SPARING REGIMENS Free

MBCL-06. SUCCESSFUL SALVAGE OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA PATIENTS TREATED ON ACNS1221 Free

MBCL-12. METASTATIC DISEASE IN THE SUPRASELLAR AREA AT DIAGNOSIS IN MEDULLOBLASTOMA Free

Email alerts

This Feature Is Available To Subscribers Only

MBCL-01. VINCRISTINE NEUROTOXICITY UNMASKING CHARCOT-MARIE-TOOTH DISEASE

MBCL-02. CURRENT ISSUES IN THE MANAGEMENT OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA IN YOUNG CHILDREN

MBCL-08. MOLECULAR CHARACTERIZATION OF NODULAR DESMOPLASTIC MEDULLOBLASTOMAS IN YOUNG CHILDREN TREATED ON ACNS1221. A REPORT FROM THE CHILDREN ONCOLOGY GROUP

MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE

MBCL-10. TREATMENT OUTCOMES AND COMPLICATION RATES OF SINGLE VERSUS TANDEM AUTOLOGOUS TRANSPLANT FOR REGIMENS FOR MEDULLOBLASTOMA

MBCL-11. CONCURRENT IDH1 AND SMARCB1 MUTATIONS IN A PEDIATRIC MEDULLOBLASTOMA: A CASE REPORT

MBCL-14. MOLECULAR GENETIS BIOMARKERS FOR PROGNISIS DEFINING IN MEDULLOBLASTOMA PATIENTS

MBCL-18. CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA

MBCL-32. SAFETY AND EFFICACY OF CONCURRENT CARBOPLATIN DURING CRANIOSPINAL IRRADIATION FOR HIGH-RISK/ MEDULLOBLASTOMA IN A RESOURCE-LIMITED SETTING

MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

MBCL-37. SECONDARY PRIMARY TUMOR AND SURVIVAL OUTCOME IN MEDULLOBLASTOMA: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) ANALYSIS

MBCL-38. MEDULLOBLASTOMAS ASSOCIATED WITH APC GERMLINE MUTATION: A MULTICENTRIC FRENCH AND BELGIAN REVIEW

MBCL-39. MEDULLOBLASTOMA IN PATIENTS WITH GORLIN SYNDROME: RESULTS FROM THE HIT STUDY GROUP

MBCL-41. TREATMENT FAILURE PATTERNS ACROSS MEDULLOBLASTOMA SUBGROUPS WITHIN A PROSPECTIVE PHASE II CLINICAL TRIAL OF RISK-ADAPTED, VOLUME-REDUCED RADIATION THERAPY AND DOSE-INTENSE CHEMOTHERAPY WITH STEM CELL SUPPORT

MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

MBCL-46. COMPOUND HETEROZYGOUS MUTATION OF THE PMS2 GENE IN AN INFANT WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY AND MEDULLOBLASTOMA

MBCL-48. HEARING CHEMOPROTECTION WITH SODIUM THIOSULFATE (STS) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH STANDARD RISK MEDULLOBLASTOMA

MBCL-49. PROGNOSTIC SIGNIFICANCE OF MOLECULAR SUBGROUPS OF MEDULLOBLASTOMA IN CHILDREN RECEIVING IRRADIATION-SPARING REGIMENS

MBCL-06. SUCCESSFUL SALVAGE OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA PATIENTS TREATED ON ACNS1221

MBCL-12. METASTATIC DISEASE IN THE SUPRASELLAR AREA AT DIAGNOSIS IN MEDULLOBLASTOMA